The inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase. Properties and function of the purified protein

T. Katada, G. M. Bokoch, J. K. Northup, M. Ui, A. G. Gilman

Research output: Contribution to journalArticle

227 Citations (Scopus)

Abstract

Treatment of membranes with islet activating protein (IAP), a toxin from Bordetella pertussis, results in abolition of GTP-dependent, receptor-mediated inhibition of adenylate cyclase. This appears to result from IAP-catalyzed ADP-ribosylation of a 41,000-Da membrane-bound protein. A protein with 41,000- and 35,000-Da subunits has been purified from rabbit liver membranes as the predominant substrate for IAP. This protein has now been shown to be capable of regulating membrane-bound adenylate cyclase activity of human platelets under various conditions. The characteristics of the actions of the IAP substrate are as follows. (1) Purified 41,000/35,000-Da dimer is capable of restoring the inhibitory effects of guanine nucleotides and the α2-adrenergic agonist, epinephrine, on the adenylate cyclase activity of IAP-treated membranes. (2) The subunits of the dimer dissociate in the presence of guanine nucleotide analogs or A13+, Mg2+, and F-. The 41,000-Da subunit has a high affinity binding site for guanine nucleotides. (3) The resolved 35,000-Da subunit of the dimer mimics guanine nucleotide- and epinephrine-induced inhibition of adenylate cyclase. (4) The resolved (unliganded) 41,000-Da subunit stimulates adenylate cyclase activity and relieves guanine nucleotide- ± epinephrine-induced inhibition of the enzyme. In contrast, the GTPγS-bound form of the 41,000-Da subunit inhibits adenylate cyclase activity, although the lower apparent affinity than does the 35,000-Da subunit. (5) The 35,000-Da subunit increases the rate of deactivation of G(s), the stimulatory regulatory protein of adenylate cyclase. In contrast, the 41,000-Da subunit can interact with G(s) and inhibit its deactivation. These data strongly suggest that the IAP substrate is another dimeric, guanine nucleotide-binding regulatory protein and that it is responsible for inhibitory modulation of adenylate cyclase activity.

Original languageEnglish (US)
Pages (from-to)3568-3577
Number of pages10
JournalJournal of Biological Chemistry
Volume259
Issue number6
StatePublished - 1984

Fingerprint

Guanine Nucleotides
Adenylyl Cyclases
Pertussis Toxin
Membranes
Proteins
Dimers
Epinephrine
Substrates
Bordetella pertussis
Adrenergic Agonists
Platelets
Guanosine Triphosphate
GTP-Binding Proteins
Human Activities
Liver
Adenosine Diphosphate
Carrier Proteins
Membrane Proteins
Blood Platelets
Binding Sites

ASJC Scopus subject areas

  • Biochemistry

Cite this

The inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase. Properties and function of the purified protein. / Katada, T.; Bokoch, G. M.; Northup, J. K.; Ui, M.; Gilman, A. G.

In: Journal of Biological Chemistry, Vol. 259, No. 6, 1984, p. 3568-3577.

Research output: Contribution to journalArticle

Katada, T. ; Bokoch, G. M. ; Northup, J. K. ; Ui, M. ; Gilman, A. G. / The inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase. Properties and function of the purified protein. In: Journal of Biological Chemistry. 1984 ; Vol. 259, No. 6. pp. 3568-3577.
@article{e6c73e808b4a48879c9b181af11954e2,
title = "The inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase. Properties and function of the purified protein",
abstract = "Treatment of membranes with islet activating protein (IAP), a toxin from Bordetella pertussis, results in abolition of GTP-dependent, receptor-mediated inhibition of adenylate cyclase. This appears to result from IAP-catalyzed ADP-ribosylation of a 41,000-Da membrane-bound protein. A protein with 41,000- and 35,000-Da subunits has been purified from rabbit liver membranes as the predominant substrate for IAP. This protein has now been shown to be capable of regulating membrane-bound adenylate cyclase activity of human platelets under various conditions. The characteristics of the actions of the IAP substrate are as follows. (1) Purified 41,000/35,000-Da dimer is capable of restoring the inhibitory effects of guanine nucleotides and the α2-adrenergic agonist, epinephrine, on the adenylate cyclase activity of IAP-treated membranes. (2) The subunits of the dimer dissociate in the presence of guanine nucleotide analogs or A13+, Mg2+, and F-. The 41,000-Da subunit has a high affinity binding site for guanine nucleotides. (3) The resolved 35,000-Da subunit of the dimer mimics guanine nucleotide- and epinephrine-induced inhibition of adenylate cyclase. (4) The resolved (unliganded) 41,000-Da subunit stimulates adenylate cyclase activity and relieves guanine nucleotide- ± epinephrine-induced inhibition of the enzyme. In contrast, the GTPγS-bound form of the 41,000-Da subunit inhibits adenylate cyclase activity, although the lower apparent affinity than does the 35,000-Da subunit. (5) The 35,000-Da subunit increases the rate of deactivation of G(s), the stimulatory regulatory protein of adenylate cyclase. In contrast, the 41,000-Da subunit can interact with G(s) and inhibit its deactivation. These data strongly suggest that the IAP substrate is another dimeric, guanine nucleotide-binding regulatory protein and that it is responsible for inhibitory modulation of adenylate cyclase activity.",
author = "T. Katada and Bokoch, {G. M.} and Northup, {J. K.} and M. Ui and Gilman, {A. G.}",
year = "1984",
language = "English (US)",
volume = "259",
pages = "3568--3577",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "6",

}

TY - JOUR

T1 - The inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase. Properties and function of the purified protein

AU - Katada, T.

AU - Bokoch, G. M.

AU - Northup, J. K.

AU - Ui, M.

AU - Gilman, A. G.

PY - 1984

Y1 - 1984

N2 - Treatment of membranes with islet activating protein (IAP), a toxin from Bordetella pertussis, results in abolition of GTP-dependent, receptor-mediated inhibition of adenylate cyclase. This appears to result from IAP-catalyzed ADP-ribosylation of a 41,000-Da membrane-bound protein. A protein with 41,000- and 35,000-Da subunits has been purified from rabbit liver membranes as the predominant substrate for IAP. This protein has now been shown to be capable of regulating membrane-bound adenylate cyclase activity of human platelets under various conditions. The characteristics of the actions of the IAP substrate are as follows. (1) Purified 41,000/35,000-Da dimer is capable of restoring the inhibitory effects of guanine nucleotides and the α2-adrenergic agonist, epinephrine, on the adenylate cyclase activity of IAP-treated membranes. (2) The subunits of the dimer dissociate in the presence of guanine nucleotide analogs or A13+, Mg2+, and F-. The 41,000-Da subunit has a high affinity binding site for guanine nucleotides. (3) The resolved 35,000-Da subunit of the dimer mimics guanine nucleotide- and epinephrine-induced inhibition of adenylate cyclase. (4) The resolved (unliganded) 41,000-Da subunit stimulates adenylate cyclase activity and relieves guanine nucleotide- ± epinephrine-induced inhibition of the enzyme. In contrast, the GTPγS-bound form of the 41,000-Da subunit inhibits adenylate cyclase activity, although the lower apparent affinity than does the 35,000-Da subunit. (5) The 35,000-Da subunit increases the rate of deactivation of G(s), the stimulatory regulatory protein of adenylate cyclase. In contrast, the 41,000-Da subunit can interact with G(s) and inhibit its deactivation. These data strongly suggest that the IAP substrate is another dimeric, guanine nucleotide-binding regulatory protein and that it is responsible for inhibitory modulation of adenylate cyclase activity.

AB - Treatment of membranes with islet activating protein (IAP), a toxin from Bordetella pertussis, results in abolition of GTP-dependent, receptor-mediated inhibition of adenylate cyclase. This appears to result from IAP-catalyzed ADP-ribosylation of a 41,000-Da membrane-bound protein. A protein with 41,000- and 35,000-Da subunits has been purified from rabbit liver membranes as the predominant substrate for IAP. This protein has now been shown to be capable of regulating membrane-bound adenylate cyclase activity of human platelets under various conditions. The characteristics of the actions of the IAP substrate are as follows. (1) Purified 41,000/35,000-Da dimer is capable of restoring the inhibitory effects of guanine nucleotides and the α2-adrenergic agonist, epinephrine, on the adenylate cyclase activity of IAP-treated membranes. (2) The subunits of the dimer dissociate in the presence of guanine nucleotide analogs or A13+, Mg2+, and F-. The 41,000-Da subunit has a high affinity binding site for guanine nucleotides. (3) The resolved 35,000-Da subunit of the dimer mimics guanine nucleotide- and epinephrine-induced inhibition of adenylate cyclase. (4) The resolved (unliganded) 41,000-Da subunit stimulates adenylate cyclase activity and relieves guanine nucleotide- ± epinephrine-induced inhibition of the enzyme. In contrast, the GTPγS-bound form of the 41,000-Da subunit inhibits adenylate cyclase activity, although the lower apparent affinity than does the 35,000-Da subunit. (5) The 35,000-Da subunit increases the rate of deactivation of G(s), the stimulatory regulatory protein of adenylate cyclase. In contrast, the 41,000-Da subunit can interact with G(s) and inhibit its deactivation. These data strongly suggest that the IAP substrate is another dimeric, guanine nucleotide-binding regulatory protein and that it is responsible for inhibitory modulation of adenylate cyclase activity.

UR - http://www.scopus.com/inward/record.url?scp=0021359584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021359584&partnerID=8YFLogxK

M3 - Article

VL - 259

SP - 3568

EP - 3577

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 6

ER -